From: Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDermâ„¢)
This study’s 2D/3D equivalent* exposures: | Alternative dose metrics for each exposure route: (as applicable) | ||||||||
---|---|---|---|---|---|---|---|---|---|
2D In-Medium (μg/mL) | 3D In-Medium (μg) | 3D Topical (μg) | 2D In-Medium (μg) | 3D In-Medium (μg/mL) | 3D Topical (μg/cm2) | 3D In-Medium (nM) | 2D In-Medium (nM) | ||
 |  |  |  |  |  | 16 nm-SiO2 | 85 nm-SiO2 | 16 nm-SiO2 | 85 nm-SiO2 |
0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.00 |
100 | 150 | 150 | 1000.0 | 167.8 | 235.9 | 49.0 | 0.33 | 29.2 | 0.19 |
200 | 300 | 300 | 2000.0 | 336.7 | 473.4 | 98.4 | 0.66 | 58.4 | 0.39 |
300 | 450 | 450 | 3000.0 | 505.6 | 710.9 | 147.7 | 0.99 | 87.7 | 0.58 |
− | 1000 | 1000 | − | 1111.1 | 1562.5 | 324.6 | 2.17 | − | − |